Table 4.
Univariable Cox analysis | ||
---|---|---|
Hazard ratio | P value | |
% ∆ LVEF, per 10% increase | 0.85 (0.64, 1.13) | 0.26 |
% ∆ LVEDVi, per 10% increase | 1.07 (0.85, 1.34) | 0.58 |
% ∆ LVESVi, per 10% increase | 1.09 (0.96, 1.22) | 0.20 |
% ∆ LV massi, per 10% increase | 1.27 (1.03, 1.56) | 0.026 |
% ∆ LV mass/LVEDV, per 0.1 increase | 1.17 (0.99, 1.39) | 0.062 |
% ∆ RVEF, per 10% increase | 0.99 (0.89, 1.10) | 0.86 |
% ∆ RVEDVi, per 10% increase | 1.01 (0.86, 1.19) | 0.87 |
% ∆ RVESVi, per 10% increase | 1.07 (0.96, 1.20) | 0.22 |
% ∆ LAVi, per 10% increase | 1.05 (0.95, 1.15) | 0.34 |
% ∆ GLS, per 1% increase | 1.00 (0.98, 1.02) | 0.93 |
% ∆ GCS, per 1% increase | 0.99 (0.97, 1.01) | 0.34 |
∆ Scar mass, per 10 g increase a | 2.34 (0.55, 10.4) | 0.24 |
∆ Scar % LV, per 10% increase a | 2.24 (0.34, 14.7) | 0.40 |
51/97 patients had late gadolinium enhancement imaging at both baseline and 1 year (9 events).